Amyloïdose
Description
Veille informationnelle portant sur l'amyloïdose
Sujets couverts
Amyloïdose
Atteintes cardiovasculaires
Diagnostic et évaluation
Interventions et pronostic
Expériences des patients et des institutions
Sources
PubMed
Fréquence
Mensuelle
Bibliothécaire responsable
Caroline Dion
caroline.dion.chum@ssss.gouv.qc.ca
Amyloïdose
-
Emerging Role of Janus Kinase Inhibitors in Primary Cutaneous Amyloidosis: A Systematic Review of 61 Reported Patients
Le 14 novembre 2026
Int J Dermatol. 2026 Oct 21. doi: 10.1111/ijd.70745. Online ahead of print. NO ABSTRACT PMID: 42908152 | DOI: 10.1111/ijd.70745
-
Musculoskeletal Manifestations of Light Chain Amyloidosis: A Systematic Review
Le 14 novembre 2026
Curr Rheumatol Rev. 2026 Oct 14. doi: 10.2174/0115733971405453260128101503. Online ahead of print. ABSTRACT INTRODUCTION: Diagnosing amyloid arthropathy remains challenging because its manifestations…
-
Quality standards for the diagnosis and management of ATTR and AL amyloidosis: a nominal group technique study
Le 14 novembre 2026
Amyloid. 2026 Oct 21:1-15. doi: 10.1080/13506129.2026.2743072. Online ahead of print. ABSTRACT BACKGROUND: Transthyretin (ATTR) and immunoglobulin light-chain (AL) amyloidosis are progressive…
-
Localized Tracheobronchial Transthyretin Amyloidosis Diagnosed After Hemoptysis: A Case Report
Le 17 octobre 2026
Respirol Case Rep. 2026 Oct 6;14(10):e70781. doi: 10.1002/rcr2.70781. eCollection 2026 Oct. ABSTRACT Pulmonary involvement in transthyretin amyloidosis (ATTR) is rare, and tracheobronchial…
-
A rare case of pulmonary amyloidosis with lymphocytic interstitial pneumonia in a patient with systemic lupus erythematosus
Le 17 octobre 2026
Clin Exp Rheumatol. 2026 Oct 6. doi: 10.55563/clinexprheumatol/g3t8q2. Online ahead of print. NO ABSTRACT PMID: 42873692 | DOI: 10.55563/clinexprheumatol/g3t8q2
-
Localised immunoglobulin light chain amyloidosis of the rectum: a rare endoscopic finding
Le 17 octobre 2026
BMJ Case Rep. 2026 Oct 14;19(10):e274860. doi: 10.1136/bcr-2026-274860. NO ABSTRACT PMID: 42875105 | DOI: 10.1136/bcr-2026-274860
-
Cerebral Amyloid Angiopathy Caused by Immunoglobulin Light Chain Amyloidosis
Le 17 octobre 2026
Can J Neurol Sci. 2026 Oct 15:1-3. doi: 10.1017/cjn.2026.10702. Online ahead of print. NO ABSTRACT PMID: 42878195 | DOI: 10.1017/cjn.2026.10702
-
Molecular Pathogenesis of Cerebral Amyloid Angiopathy in Alzheimer's Disease: The Role of the Central Fibrinolytic Cascade at the Neurovascular Unit
Le 17 octobre 2026
Mol Neurobiol. 2026 Oct 15;63(1):969. doi: 10.1007/s12035-026-06263-3. ABSTRACT Alzheimer's disease (AD) is increasingly recognized as a multifactorial neurodegenerative disorder involving complex…
-
Amyloid goitre in cryptogenic AA amyloidosis: contrasting thyroid phenotypes and proteomic typing
Le 17 octobre 2026
QJM. 2026 Oct 10:hcag290. doi: 10.1093/qjmed/hcag290. Online ahead of print. NO ABSTRACT PMID: 42860057 | DOI: 10.1093/qjmed/hcag290
-
Aggressive mediastinal amyloidosis mimicking malignancy: a case report
Le 17 octobre 2026
Int J Surg Case Rep. 2026 Sep 1;138(10):4161-4166. doi: 10.1097/RC9.0000000000000925. eCollection 2026 Oct. ABSTRACT INTRODUCTION: Amyloidosis is characterized by extracellular protein fibril…
Atteintes cardiovasculaires
-
The spectrum of amyloid cardiovascular disease
Le 14 novembre 2026
Heart Fail Rev. 2026 Nov 9;31(1):120. doi: 10.1007/s10741-026-10693-5. ABSTRACT Cardiac amyloidosis, historically characterized as a restrictive cardiomyopathy, is now understood as a multi…
-
The Arrhythmic Burden of Cardiac Amyloidosis: A Comprehensive Review
Le 17 octobre 2026
Heart Views. 2026 Aug 25;27:5. doi: 10.4103/heartviews.heartviews_167_25. eCollection 2026. ABSTRACT Cardiac amyloidosis (CA) represents a growing etiology of heart failure (HF) and arrhythmogenesis,…
-
Multimodal artificial intelligence to predict cardiomyopathy development in hereditary transthyretin amyloidosis
Le 17 octobre 2026
Open Heart. 2026 Oct 9;13(2):e004243. doi: 10.1136/openhrt-2026-004243. NO ABSTRACT PMID: 42869491 | DOI: 10.1136/openhrt-2026-004243
-
Arrhythmias in patients with transthyretin cardiac amyloidosis and the impact of contemporary disease-modifying therapies
Le 17 octobre 2026
J Cardiovasc Med (Hagerstown). 2026 Oct 1;27(10):786-797. doi: 10.2459/JCM.0000000000001944. Epub 2026 Oct 2. ABSTRACT Transthyretin cardiac amyloidosis (ATTR-CM) is an increasingly recognized…
-
Screening for patients at risk for cardiac amyloidosis via electronic health records: A multicenter machine learning development and validation study
Le 17 octobre 2026
PLOS Digit Health. 2026 Oct 8;5(10):e0001637. doi: 10.1371/journal.pdig.0001637. eCollection 2026 Oct. ABSTRACT Timely detection is crucial to improve outcomes in patients with cardiac amyloidosis …
-
Cardiac amyloidosis: what every interventional cardiologist should know
Le 17 octobre 2026
Cardiovasc Interv Ther. 2026 Oct 8. doi: 10.1007/s12928-026-01358-z. Online ahead of print. ABSTRACT Cardiac amyloidosis (CA) is increasingly encountered by interventional cardiologists during the…
-
Cardiac amyloidosis and coronary artery disease: an overlooked clinical intersection
Le 17 octobre 2026
Coron Artery Dis. 2026 Sep 29. doi: 10.1097/MCA.0000000000001679. Online ahead of print. ABSTRACT Cardiac amyloidosis has emerged as an important and underrecognized cause of heart failure with…
Diagnostic et évaluation
-
Cardiac amyloidosis: the role of multimodality imaging
Le 14 novembre 2026
Neth Heart J. 2026 Nov 10. doi: 10.1007/s12471-026-02092-0. Online ahead of print. ABSTRACT Cardiac amyloidosis is an increasingly recognized cause of heart failure, driven by advances in diagnostic…
-
Detection, Monitoring, and Discrimination of Amyloidogenic vs Innocent Light Chains in Systemic Amyloidoses
Le 14 novembre 2026
Blood. 2026 Nov 9:blood.2026034465. doi: 10.1182/blood.2026034465. Online ahead of print. ABSTRACT Immunoglobulin light chains (LCs) span the spectrum of B-cell clonal disorders from monoclonal…
-
Family screening and genetic testing in transthyretin cardiac amyloidosis : Changing (not only) variant transthyretin cardiac amyloidosis
Le 14 novembre 2026
Neth Heart J. 2026 Nov 9. doi: 10.1007/s12471-026-02088-w. Online ahead of print. ABSTRACT With increasing awareness of transthyretin amyloid cardiomyopathy (ATTR-CM) as a cause of heart failure and…
-
Multicentre study of activity quantification methods for 99m-Tc-pyrophosphate SPECT/CT in cardiac amyloidosis
Le 14 novembre 2026
Phys Med. 2026 Nov 5;152:107217. doi: 10.1016/j.ejmp.2026.107217. Online ahead of print. ABSTRACT OBJECTIVE: 99mTc-PYP SPECT/CT imaging is used for diagnosis of transthyretin cardiac amyloidosis …
-
Amyloid-targeted PET after negative or low-grade bone scintigraphy for cardiac amyloidosis: a systematic review
Le 14 novembre 2026
Int J Cardiovasc Imaging. 2026 Oct 23. doi: 10.1007/s10554-026-03852-0. Online ahead of print. ABSTRACT To assess myocardial positron emission tomography (PET) positivity after negative or low-grade…
-
Screening Criteria for Amyloidosis Biopsy Testing during Carpal Tunnel Release in Community Hospitals: Evaluation and Application
Le 17 octobre 2026
J Wrist Surg. 2025 Oct 14;15(5):459-464. doi: 10.1055/a-2710-9610. eCollection 2026 Oct. ABSTRACT BACKGROUND: Carpal tunnel syndrome (CTS) is a common disorder caused by median nerve compression…
-
Clinical manifestations and cardiac abnormalities in systemic Amyloid A Amyloidosis
Le 17 octobre 2026
Int J Cardiol. 2026 Oct 8:134973. doi: 10.1016/j.ijcard.2026.134973. Online ahead of print. ABSTRACT BACKGROUND: Cardiac involvement in systemic amyloid A (AA) amyloidosis is traditionally considered…
-
AA amyloidosis as a rare presentation leading to the diagnosis of mevalonate kinase deficiency in a male adult: a diagnostic challenge mimicking familial Mediterranean fever
Le 17 octobre 2026
Clin Exp Rheumatol. 2026 Oct 9. doi: 10.55563/clinexprheumatol/0rs4nj. Online ahead of print. NO ABSTRACT PMID: 42873706 | DOI: 10.55563/clinexprheumatol/0rs4nj
-
Pulmonary Amyloidosis Diagnosed by Transbronchial Lung Biopsy: A Three-Case Series With Diverse Radiological Manifestations
Le 17 octobre 2026
Respirol Case Rep. 2026 Sep 15;14(9):e70757. doi: 10.1002/rcr2.70757. eCollection 2026 Sep. ABSTRACT Pulmonary amyloidosis is a rare disease with diverse radiological manifestations that may mimic…
Interventions et pronostic
-
Impact of daratumumab on stem cell collection in patients with AL amyloidosis
Le 14 novembre 2026
BMC Cancer. 2026 Nov 3;26(1):1403. doi: 10.1186/s12885-026-17227-0. ABSTRACT BACKGROUND: Autologous stem cell transplantation following high-dose melphalan is an effective consolidation therapy for…
-
Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific Workshop
Le 17 octobre 2026
Amyloid. 2026 Oct 5:1-14. doi: 10.1080/13506129.2026.2735581. Online ahead of print. ABSTRACT BACKGROUND: Amyloidosis is caused by deposition of misfolded proteins as amyloid fibrils in multiple…
-
Rapid therapeutic response in refractory lichen amyloidosis treated with upadacitinib: a case report
Le 17 octobre 2026
Front Med (Lausanne). 2026 Sep 22;13:1932492. doi: 10.3389/fmed.2026.1932492. eCollection 2026. ABSTRACT Lichen amyloidosis (LA) is an intractable, chronic pruritic skin disorder characterized by…
-
From limited options to therapeutic innovation: the changing landscape of transthyretin amyloidosis
Le 17 octobre 2026
Eur J Hosp Pharm. 2026 Sep 29:ejhpharm-2026-005372. doi: 10.1136/ejhpharm-2026-005372. Online ahead of print. NO ABSTRACT PMID: 42810846 | DOI: 10.1136/ejhpharm-2026-005372
-
Eplontersen for the Treatment of Hereditary Transthyretin Amyloidosis
Le 17 octobre 2026
Methods Mol Biol. 2026;3065:137-147. doi: 10.1007/978-1-0716-5476-7_8. ABSTRACT Hereditary transthyretin-mediated amyloidosis (ATTRv) is an autosomal dominant disease and the most common form of…
Expériences des patients et des institutions
-
The pathophysiology of wild-type transthyretin amyloidosis: implications for exercise intolerance
Le 17 octobre 2026
Am J Physiol Heart Circ Physiol. 2026 Nov 1;331(5):H1530-H1545. doi: 10.1152/ajpheart.00430.2026. Epub 2026 Sep 18. ABSTRACT Wild-type transthyretin amyloidosis (ATTRwt) is an age-associated protein…
-
Amyloidosis & Advanced Heart Failure: When to Consider Cardiac Transplantation and What are the Results?
Le 10 septembre 2026
Curr Heart Fail Rep. 2026 Sep 8;23(1):44. doi: 10.1007/s11897-026-00777-6. ABSTRACT PURPOSE OF REVIEW: The management of end-stage heart failure in cardiac amyloidosis due to both light chain (AL-CA)…
-
Psycho-Emotional Profile and Disease Burden in Wild-Type Transthyretin Amyloidosis
Le 10 septembre 2026
J Clin Med. 2026 Aug 17;15(16):6348. doi: 10.3390/jcm15166348. ABSTRACT Background/Objectives: Patients with transthyretin amyloidosis frequently experience reduced quality of life, distress, anxiety…
-
In-Hospital Outcomes of Sepsis Hospitalizations Among Patients With Cardiac Amyloidosis: A 2022 National Inpatient Sample Analysis
Le 6 août 2026
Curr Probl Cardiol. 2026 Jul 18:103404. doi: 10.1016/j.cpcardiol.2026.103404. Online ahead of print. ABSTRACT BACKGROUND: Cardiac amyloidosis is characterized by restrictive physiology and limited…
